See more : Orchestra Holdings Inc. (6533.T) Income Statement Analysis – Financial Results
Complete financial analysis of InBody Co.,Ltd (041830.KQ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of InBody Co.,Ltd, a leading company in the Medical – Specialties industry within the Healthcare sector.
- abrdn Asia Focus plc (AAS.L) Income Statement Analysis – Financial Results
- Aerison Group Ltd (AE1.AX) Income Statement Analysis – Financial Results
- Fastned B.V. (FAST.AS) Income Statement Analysis – Financial Results
- Eurotex Industries and Exports Limited (EUROTEXIND.NS) Income Statement Analysis – Financial Results
- Winstar Display Co., Ltd. (6916.TW) Income Statement Analysis – Financial Results
InBody Co.,Ltd (041830.KQ)
About InBody Co.,Ltd
InBody Co.,Ltd provides body composition analysis solutions worldwide. The company offers body composition analyzers, blood pressure monitors, stadiometers, and body water analyzers, as well as InBody dial and bands. Its products are used in nephrology, liver disease, diabetes, nutrition, and rehabilitation applications. The company was formerly known as Biospace Co., Ltd. InBody Co.,Ltd was founded in 1996 and is headquartered in Seoul, South Korea.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 170.35B | 160.00B | 137.84B | 107.12B | 117.06B | 99.64B | 93.25B | 79.85B | 68.95B | 48.94B | 36.79B | 33.23B |
| Cost of Revenue | 38.52B | 42.87B | 39.95B | 33.24B | 33.94B | 27.85B | 24.85B | 23.04B | 20.40B | 14.77B | 10.91B | 9.62B |
| Gross Profit | 131.83B | 117.13B | 97.88B | 73.88B | 83.12B | 71.78B | 68.41B | 56.81B | 48.55B | 34.17B | 25.87B | 23.61B |
| Gross Profit Ratio | 77.39% | 73.20% | 71.01% | 68.97% | 71.00% | 72.05% | 73.36% | 71.14% | 70.41% | 69.81% | 70.34% | 71.04% |
| Research & Development | 9.31B | 8.78B | 8.06B | 5.80B | 5.24B | 5.21B | 7.25B | 5.38B | 4.88B | 3.39B | 2.71B | 2.29B |
| General & Administrative | 5.96B | 4.49B | 3.71B | 3.95B | 562.90M | 557.03M | 580.54M | 507.23M | 388.85M | 381.38M | 238.51M | 306.03M |
| Selling & Marketing | 26.69B | 21.26B | 16.73B | 13.59B | 14.11B | 11.46B | 9.93B | 7.34B | 6.81B | 6.53B | 4.87B | 3.77B |
| SG&A | 78.05B | 66.71B | 52.65B | 47.25B | 49.16B | 41.90B | 35.35B | 28.75B | 22.80B | 19.68B | 15.92B | 15.79B |
| Other Expenses | 0.00 | -934.01M | -1.32B | -1.91B | -1.14B | -993.50M | -1.04B | -639.08M | -855.12M | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 87.36B | 76.43B | 62.03B | 54.96B | 55.54B | 48.11B | 43.65B | 34.76B | 28.54B | 24.17B | 19.34B | 18.41B |
| Cost & Expenses | 125.88B | 119.30B | 101.99B | 88.20B | 89.49B | 75.96B | 68.49B | 57.81B | 48.94B | 38.94B | 30.26B | 28.03B |
| Interest Income | 3.23B | 1.48B | 681.91M | 528.19M | 441.17M | 437.28M | 635.94M | 536.01M | 657.29M | 669.64M | 525.11M | 816.80M |
| Interest Expense | 329.51M | 121.99M | 103.50M | 124.47M | 140.70M | 122.54M | 160.00 | 3.00 | 1.00 | 0.00 | 1.00 | 0.00 |
| Depreciation & Amortization | 5.96B | 5.37B | 4.44B | 4.51B | 3.98B | 2.02B | 1.75B | 1.75B | 1.37B | 1.11B | 922.31M | 573.75M |
| EBITDA | 44.26B | 46.08B | 43.77B | 23.52B | 32.30B | 25.69B | 26.65B | 23.79B | 21.38B | 11.20B | 7.40B | 5.58B |
| EBITDA Ratio | 25.98% | 28.80% | 29.23% | 21.87% | 26.96% | 25.79% | 28.43% | 29.79% | 31.00% | 22.89% | 20.12% | 16.78% |
| Operating Income | 44.47B | 40.70B | 35.85B | 18.92B | 27.57B | 23.68B | 24.76B | 22.04B | 20.01B | 10.10B | 6.48B | 5.00B |
| Operating Income Ratio | 26.10% | 25.44% | 26.01% | 17.66% | 23.55% | 23.76% | 26.55% | 27.60% | 29.02% | 20.63% | 17.61% | 15.05% |
| Total Other Income/Expenses | 129.91M | 1.93B | -1.20B | 1.52B | 553.63M | -1.04B | -1.35B | -1.26B | -573.64M | -425.50M | -190.05M | 1.01B |
| Income Before Tax | 44.60B | 42.63B | 39.23B | 20.62B | 28.18B | 24.59B | 23.41B | 20.78B | 20.75B | 10.67B | 7.06B | 6.01B |
| Income Before Tax Ratio | 26.18% | 26.64% | 28.46% | 19.25% | 24.07% | 24.68% | 25.10% | 26.03% | 30.09% | 21.79% | 19.18% | 18.10% |
| Income Tax Expense | 8.04B | 8.66B | 5.35B | 3.11B | 7.81B | 5.04B | 4.08B | 3.82B | 3.46B | 1.79B | 860.93M | 370.28M |
| Net Income | 36.72B | 33.82B | 34.03B | 17.52B | 20.43B | 19.67B | 19.32B | 16.99B | 17.31B | 8.88B | 6.19B | 5.64B |
| Net Income Ratio | 21.56% | 21.13% | 24.69% | 16.35% | 17.45% | 19.74% | 20.72% | 21.27% | 25.11% | 18.14% | 16.84% | 16.98% |
| EPS | 2.82K | 2.60K | 2.61K | 1.34K | 1.53K | 1.46K | 1.43K | 1.25K | 1.27K | 652.00 | 455.00 | 415.00 |
| EPS Diluted | 2.82K | 2.60K | 2.61K | 1.34K | 1.53K | 1.46K | 1.43K | 1.25K | 1.27K | 652.00 | 455.00 | 415.00 |
| Weighted Avg Shares Out | 13.03M | 13.03M | 13.03M | 13.12M | 13.34M | 13.48M | 13.51M | 13.61M | 13.61M | 13.62M | 13.61M | 13.60M |
| Weighted Avg Shares Out (Dil) | 13.03M | 13.03M | 13.03M | 13.12M | 13.34M | 13.48M | 13.51M | 13.61M | 13.61M | 13.62M | 13.61M | 13.60M |
INSERTING and REPLACING CES 2017 Exhibitor Profiles: HAIRMAX to LUXROBO
Source: https://incomestatements.info
Category: Stock Reports